PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
CertaraOctober 23, 2020
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
CertaraOctober 20, 2020
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
Having the ability to scale with research needs is pivotal to success. Understanding when the…
CertaraOctober 12, 2020
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in…
CertaraOctober 12, 2020
Formatting Annotated Case Report Forms (aCRFs): Multiple copies and/or multiple versions of forms
Streamline aCRF formatting by mastering versions, repeated pages, and compliance essentials. Read the third blog…
CertaraOctober 9, 2020
Stay on Track and Get Some Sleep: Marketing Application Best Practices
Without careful execution and the ability to navigate unexpected challenges, marketing application submissions are prone…
CertaraOctober 7, 2020
Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies
Safety issues account for about a quarter of the attrition in drug projects, and can…
CertaraOctober 5, 2020
